The Claim
Dichloroacetate (DCA, 25 mM) shifts glucose metabolism from glycolysis to mitochondrial oxidative phosphorylation in patient-derived DIPG cell lines, resulting in reduced extracellular acidification and reduced intracellular lactate production.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In brain cancer cells derived from patients, dichloroacetate changes how the cells use glucose, causing them to produce less acid and less lactate by increasing energy production in mitochondria.
See the scientific wording
Dichloroacetate (DCA, 25 mM) shifts glucose metabolism from glycolysis to mitochondrial oxidative phosphorylation in patient-derived DIPG cell lines, reducing extracellular acidification and intracellular lactate production, consistent with its known mechanism of inhibiting pyruvate dehydrogenase kinase.
DCA blocks a protein that normally stops pyruvate from entering the mitochondria. This forces pyruvate into the mitochondria to be burned for energy instead of being turned into lactate. As a result, the cell produces less acid and less lactate because it stops relying on glycolysis and starts using the mitochondria for energy.
What the research says
1 studyThe study found that DCA, a chemical, makes brain tumor cells stop making too much lactic acid and instead use their energy factories (mitochondria) more efficiently — just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.